Sign in

CIK 0001842295 · Non-accelerated filer<br>Emerging growth company

Maze Therapeutics, Inc.

Sign in to watch
Ticker
MAZE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6508505070
Business address
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
  1. DRS/A Other Draft Registration Statement
  2. DRSLTR Other Correspondence Related to Draft Registration Statement
  3. DRS/A Other Draft Registration Statement
  4. DRSLTR Other Correspondence Related to Draft Registration Statement
  5. DRS/A Other Draft Registration Statement
  6. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  7. DRS Other Draft Registration Statement

Page 3 of 3 · 47 filings